Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Antidepressant Use During Pregnancy May Lengthen Umbilical Cord

May 9, 2016 9:29 am | by PLOS ONE | News | Comments

Umbilical cords of children whose mothers used selective serotonin reuptake inhibitors during pregnancy may be longer than umbilical cords of other newborn children, shows a new study.


Intarcia Preps FDA Filing for Revolutionary Diabetes Drug

May 9, 2016 9:28 am | by Ryan Bushey, Digital Editor | Articles | Comments

More than 4,000 type 2 diabetes patients took part in this placebo-controlled global study over the course of three years.


E-Cigarette Poisonings Surge in Young Children, Study Says

May 9, 2016 9:22 am | by Lauren Neergaard, AP Medical Writer | News | Comments

Electronic cigarettes have sickened rising numbers of young children, a study of U.S. poison center calls has found. Most cases involve swallowing liquid nicotine.


Drug-like Peptides Show Promise in Treating 2 Blood Diseases

May 6, 2016 3:30 pm | by Children's Hospital of Pennsylvania | News | Comments

New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults.


A New Paper-Based Test for the Zika Virus

May 6, 2016 2:30 pm | by Anne Trafton, MIT News Office | News | Comments

The test can be stored at room temperature and read with a simple electronic reader.


Valeant Forms Internal Committee to Oversee Drug Pricing

May 6, 2016 1:30 pm | by Deena Beasley, Reuters | News | Comments

The committee is made up of a team of Valeant employees including doctors, scientists and other executives.


NICE Recommends Praluent, Repatha for Treating Cholesterol

May 6, 2016 12:55 pm | News | Comments

The draft guidance recommends the drugs, which are not licensed for everyone who has high cholesterol levels, only if they are provided at the discounted price agreed with the companies.


Long-Term Warfarin Use for AF Linked to Dementia Risk

May 6, 2016 12:10 pm | by Stephanie Guzowski, Editor | News | Comments

Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with the blood thinner, warfarin, may have higher rates of dementia, according to a recent study of more than 10,000 patients.


Allergan Receives FDA Approval to Launch First Generic Version of Crestor

May 6, 2016 9:34 am | News | Comments

Allergan is the first company to launch a generic version of of this drug to customers in the U.S.


Newly Revealed Epigenome Complexity Offers Clues for Regulatory Function

May 6, 2016 9:29 am | by Jonas Korlach, Chief Scientific Officer, PacBio | Articles | Comments

In recent years, it has become clear that the impact of epigenetics is more common and complex than previously suspected, underscoring the need to conduct in-depth studies of these mechanisms.


Medivation: No to Sanofi's Renewed Press to Take $9.3B Offer

May 6, 2016 9:24 am | by Linda A. Johnson, AP Business Writer | News | Comments

The swift response came hours after Paris-based Sanofi, France's biggest drugmaker, threatened Medivation's board members with possible removal if they won't discuss a deal.


Popular Heartburn Drugs May Cause Serious Kidney Damage

May 6, 2016 9:04 am | by Washington University in St. Louis | News | Comments

More than 15 million Americans have prescriptions for so-called proton pump inhibitors (PPIs), which decrease gastric acid production and generally have been considered safe.


Scripps Florida Awarded $2.5M to Advance Development of RNA-Based Therapeutics

May 6, 2016 8:51 am | by TSRI | News | Comments

The new grant will enable Disney and his team to further investigate the manipulation of microRNAs.


Researchers Find Alternative Pathways to HIV Antibodies

May 6, 2016 8:28 am | by Duke University | News | Comments

The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection.


Eli Lilly Granted Priority Review for Soft Tissue Sarcoma Drug

May 6, 2016 8:27 am | News | Comments

Lilly has received additional designations for olaratumab from the FDA.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.